Johnson & Johnson’s one-dose vaccine is effective in preventing severe and fatal coronavirus cases, and may reduce the virus’s transmission among vaccinated people, the FDA said in new analyses Wednesday.
The drug maker announced in January that its vaccine was 72% effective against the virus in the United States and 64% effective in South Africa, where a mutated, more transmissible strain has become dominant. Its vaccine was 86% effective in preventing severe virus cases in the U.S., meaning that a vaccinated individual is at a far smaller risk of being hospitalized or dying from COVID-19.
The Daily Caller was founded in 2010 by Tucker Carlson, a 20-year veteran journalist, and Neil Patel, former chief policy advisor to Vice President Cheney, The Daily Caller is one of America’s largest and fastest-growing news publications. Our team of experienced, full-time reporters and editors works around the clock to deliver award-winning original reporting, in-depth investigations, entertainment, thought-provoking commentary and up-to-the-second breaking news. Visit https://dailycaller.com